カテゴリー： QYResearch, 世界, 医療/バイオ

世界の鉄欠乏性貧血治療市場インサイト及び予測（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）

◆英語タイトル：Global Iron Deficiency Anemia Treatment Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09240 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：91 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、鉄欠乏性貧血治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に鉄欠乏性貧血治療の世界市場のxxx％を占める「硫酸第一鉄」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
鉄欠乏性貧血治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの鉄欠乏性貧血治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

鉄欠乏性貧血治療のグローバル主要企業には、AdvaCare Pharma、Akorn、Sun Pharmaceutical Industries Ltd.、Akebia Therapeutics, Inc.、Rockwell Medical, Inc.、Vifor Pharma Management Ltd.、Shield Therapeutics、AMAG Pharmaceuticals、Pharmacosmos A/Sなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

鉄欠乏性貧血治療市場は、種類と用途によって区分されます。世界の鉄欠乏性貧血治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他

【用途別セグメント】
病院薬局、小売薬局、オンライン薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 鉄欠乏性貧血治療製品概要
- 種類別市場（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）
- 用途別市場（病院薬局、小売薬局、オンライン薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の鉄欠乏性貧血治療販売量予測2017-2028
- 世界の鉄欠乏性貧血治療売上予測2017-2028
- 鉄欠乏性貧血治療の地域別販売量
- 鉄欠乏性貧血治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別鉄欠乏性貧血治療販売量
- 主要メーカー別鉄欠乏性貧血治療売上
- 主要メーカー別鉄欠乏性貧血治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）
- 鉄欠乏性貧血治療の種類別販売量
- 鉄欠乏性貧血治療の種類別売上
- 鉄欠乏性貧血治療の種類別価格
・用途別市場規模（病院薬局、小売薬局、オンライン薬局）
- 鉄欠乏性貧血治療の用途別販売量
- 鉄欠乏性貧血治療の用途別売上
- 鉄欠乏性貧血治療の用途別価格
・北米市場
- 北米の鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの鉄欠乏性貧血治療市場規模（種類別、用途別）
- 主要国別の鉄欠乏性貧血治療市場規模（トルコ、サウジアラビア）
・企業情報
AdvaCare Pharma、Akorn、Sun Pharmaceutical Industries Ltd.、Akebia Therapeutics, Inc.、Rockwell Medical, Inc.、Vifor Pharma Management Ltd.、Shield Therapeutics、AMAG Pharmaceuticals、Pharmacosmos A/S
・産業チェーン及び販売チャネル分析
- 鉄欠乏性貧血治療の産業チェーン分析
- 鉄欠乏性貧血治療の原材料
- 鉄欠乏性貧血治療の生産プロセス
- 鉄欠乏性貧血治療の販売及びマーケティング
- 鉄欠乏性貧血治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 鉄欠乏性貧血治療の産業動向
- 鉄欠乏性貧血治療のマーケットドライバー
- 鉄欠乏性貧血治療の課題
- 鉄欠乏性貧血治療の阻害要因
・主な調査結果

People with iron deficiency and mild to moderate anemia are mainly treated with oral iron, and their diets should be improved to eat iron-rich foods. Severe anemia can be treated with oral iron or intravenous iron, as well as a small number of repeated infusions of packed red blood cells. However, intravenous iron supplementation is not recommended during the first trimester.
Market Analysis and Insights: Global Iron Deficiency Anemia Treatment Market
Due to the COVID-19 pandemic, the global Iron Deficiency Anemia Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Ferrous Sulfate accounting for % of the Iron Deficiency Anemia Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Iron Deficiency Anemia Treatment market size is valued at US$ million in 2021, while the US and Europe Iron Deficiency Anemia Treatment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Iron Deficiency Anemia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Iron Deficiency Anemia Treatment include AdvaCare Pharma, Akorn, Sun Pharmaceutical Industries Ltd., Akebia Therapeutics, Inc., Rockwell Medical, Inc., Vifor Pharma Management Ltd., Shield Therapeutics, AMAG Pharmaceuticals and Pharmacosmos A/S. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Iron Deficiency Anemia Treatment Scope and Segment
Iron Deficiency Anemia Treatment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Iron Deficiency Anemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ferrous Sulfate
Ferrous Gluconate
Ferrous Fumerate
Ferric Hydroxide
Sodium Ferric Gluconate
Iron Carbohydrates
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Company
AdvaCare Pharma
Akorn
Sun Pharmaceutical Industries Ltd.
Akebia Therapeutics, Inc.
Rockwell Medical, Inc.
Vifor Pharma Management Ltd.
Shield Therapeutics
AMAG Pharmaceuticals
Pharmacosmos A/S
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Iron Deficiency Anemia Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Iron Deficiency Anemia Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ferrous Sulfate
1.2.3 Ferrous Gluconate
1.2.4 Ferrous Fumerate
1.2.5 Ferric Hydroxide
1.2.6 Sodium Ferric Gluconate
1.2.7 Iron Carbohydrates
1.2.8 Others
1.3 Market by Application
1.3.1 Global Iron Deficiency Anemia Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Iron Deficiency Anemia Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Iron Deficiency Anemia Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Iron Deficiency Anemia Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Iron Deficiency Anemia Treatment Sales by Region
2.4.1 Global Iron Deficiency Anemia Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Iron Deficiency Anemia Treatment by Region (2023-2028)
2.5 Global Iron Deficiency Anemia Treatment Revenue by Region
2.5.1 Global Iron Deficiency Anemia Treatment Revenue by Region (2017-2022)
2.5.2 Global Iron Deficiency Anemia Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Iron Deficiency Anemia Treatment Sales by Manufacturers
3.1.1 Global Top Iron Deficiency Anemia Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Iron Deficiency Anemia Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Iron Deficiency Anemia Treatment in 2021
3.2 Global Iron Deficiency Anemia Treatment Revenue by Manufacturers
3.2.1 Global Iron Deficiency Anemia Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Iron Deficiency Anemia Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Iron Deficiency Anemia Treatment Revenue in 2021
3.3 Global Iron Deficiency Anemia Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Iron Deficiency Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Iron Deficiency Anemia Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Iron Deficiency Anemia Treatment Sales by Type
4.1.1 Global Iron Deficiency Anemia Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Iron Deficiency Anemia Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Iron Deficiency Anemia Treatment Sales Market Share by Type (2017-2028)
4.2 Global Iron Deficiency Anemia Treatment Revenue by Type
4.2.1 Global Iron Deficiency Anemia Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Iron Deficiency Anemia Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Iron Deficiency Anemia Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Iron Deficiency Anemia Treatment Price by Type
4.3.1 Global Iron Deficiency Anemia Treatment Price by Type (2017-2022)
4.3.2 Global Iron Deficiency Anemia Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Iron Deficiency Anemia Treatment Sales by Application
5.1.1 Global Iron Deficiency Anemia Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Iron Deficiency Anemia Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Iron Deficiency Anemia Treatment Sales Market Share by Application (2017-2028)
5.2 Global Iron Deficiency Anemia Treatment Revenue by Application
5.2.1 Global Iron Deficiency Anemia Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Iron Deficiency Anemia Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Iron Deficiency Anemia Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Iron Deficiency Anemia Treatment Price by Application
5.3.1 Global Iron Deficiency Anemia Treatment Price by Application (2017-2022)
5.3.2 Global Iron Deficiency Anemia Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Iron Deficiency Anemia Treatment Market Size by Type
6.1.1 North America Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
6.1.2 North America Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
6.2 North America Iron Deficiency Anemia Treatment Market Size by Application
6.2.1 North America Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
6.2.2 North America Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
6.3 North America Iron Deficiency Anemia Treatment Market Size by Country
6.3.1 North America Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
6.3.2 North America Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Iron Deficiency Anemia Treatment Market Size by Type
7.1.1 Europe Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
7.1.2 Europe Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
7.2 Europe Iron Deficiency Anemia Treatment Market Size by Application
7.2.1 Europe Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
7.2.2 Europe Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
7.3 Europe Iron Deficiency Anemia Treatment Market Size by Country
7.3.1 Europe Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
7.3.2 Europe Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Type
8.1.1 Asia Pacific Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Application
8.2.1 Asia Pacific Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Region
8.3.1 Asia Pacific Iron Deficiency Anemia Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Iron Deficiency Anemia Treatment Market Size by Type
9.1.1 Latin America Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
9.1.2 Latin America Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
9.2 Latin America Iron Deficiency Anemia Treatment Market Size by Application
9.2.1 Latin America Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
9.2.2 Latin America Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
9.3 Latin America Iron Deficiency Anemia Treatment Market Size by Country
9.3.1 Latin America Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
9.3.2 Latin America Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Type
10.1.1 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Application
10.2.1 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Country
10.3.1 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AdvaCare Pharma
11.1.1 AdvaCare Pharma Corporation Information
11.1.2 AdvaCare Pharma Overview
11.1.3 AdvaCare Pharma Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AdvaCare Pharma Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AdvaCare Pharma Recent Developments
11.2 Akorn
11.2.1 Akorn Corporation Information
11.2.2 Akorn Overview
11.2.3 Akorn Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Akorn Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Akorn Recent Developments
11.3 Sun Pharmaceutical Industries Ltd.
11.3.1 Sun Pharmaceutical Industries Ltd. Corporation Information
11.3.2 Sun Pharmaceutical Industries Ltd. Overview
11.3.3 Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments
11.4 Akebia Therapeutics, Inc.
11.4.1 Akebia Therapeutics, Inc. Corporation Information
11.4.2 Akebia Therapeutics, Inc. Overview
11.4.3 Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Akebia Therapeutics, Inc. Recent Developments
11.5 Rockwell Medical, Inc.
11.5.1 Rockwell Medical, Inc. Corporation Information
11.5.2 Rockwell Medical, Inc. Overview
11.5.3 Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rockwell Medical, Inc. Recent Developments
11.6 Vifor Pharma Management Ltd.
11.6.1 Vifor Pharma Management Ltd. Corporation Information
11.6.2 Vifor Pharma Management Ltd. Overview
11.6.3 Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Vifor Pharma Management Ltd. Recent Developments
11.7 Shield Therapeutics
11.7.1 Shield Therapeutics Corporation Information
11.7.2 Shield Therapeutics Overview
11.7.3 Shield Therapeutics Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shield Therapeutics Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shield Therapeutics Recent Developments
11.8 AMAG Pharmaceuticals
11.8.1 AMAG Pharmaceuticals Corporation Information
11.8.2 AMAG Pharmaceuticals Overview
11.8.3 AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AMAG Pharmaceuticals Recent Developments
11.9 Pharmacosmos A/S
11.9.1 Pharmacosmos A/S Corporation Information
11.9.2 Pharmacosmos A/S Overview
11.9.3 Pharmacosmos A/S Iron Deficiency Anemia Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pharmacosmos A/S Iron Deficiency Anemia Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pharmacosmos A/S Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Iron Deficiency Anemia Treatment Industry Chain Analysis
12.2 Iron Deficiency Anemia Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Iron Deficiency Anemia Treatment Production Mode & Process
12.4 Iron Deficiency Anemia Treatment Sales and Marketing
12.4.1 Iron Deficiency Anemia Treatment Sales Channels
12.4.2 Iron Deficiency Anemia Treatment Distributors
12.5 Iron Deficiency Anemia Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Iron Deficiency Anemia Treatment Industry Trends
13.2 Iron Deficiency Anemia Treatment Market Drivers
13.3 Iron Deficiency Anemia Treatment Market Challenges
13.4 Iron Deficiency Anemia Treatment Market Restraints
14 Key Findings in The Global Iron Deficiency Anemia Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の鉄欠乏性貧血治療市場インサイト及び予測（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）(Global Iron Deficiency Anemia Treatment Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の鉄欠乏性貧血治療市場インサイト及び予測（硫酸第一鉄、グルコン酸第一鉄、フメン酸第一鉄、水酸化第二鉄、グルコン酸第二鉄ナトリウム、鉄炭水化物、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp